Therapeutic drug monitoring and safety evaluation of voriconazole in the treatment of pulmonary fungal diseases.

Authors:
Shen K; Gu Y; Wang Y; Lu Y; Ni Y and 3 more

Journal:
Ther Adv Drug Saf

Publication Year: 2022

DOI:
10.1177/20420986221127503

PMCID:
PMC9549188

PMID:
36225945

Journal Information

Full Title: Ther Adv Drug Saf

Abbreviation: Ther Adv Drug Saf

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology & Pharmacy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"The author declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article."

Evidence found in paper:

"Funding: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the Natural Science Foundation of China project (grant no. 82270019), the Natural Science Foundation of China project (grant no. 82070011) and the Key Project of Jiangsu Commission of Health (grant no. K2019004). The fund had no role in the design of the study, collection, analysis, and interpretation of data and in writing the manuscript."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025